“Our stroke study was at a critical level of under-enrollment more than a year into the study. ICTS developed an innovative approach that filled the remaining 86% of our enrollment goal six weeks after deployment.”
Project Director, Top 50 Pharmaceutical Company

Retention and Compliance

Maintaining qualified subjects is as important as obtaining qualified subject

  • Addressing Compliance at Consent
  • Patient Communication Tools
    • Quality of Life Assessments
    • Patient Welcome and Thank-you
    • Newsletters
    • Study Appointment Reminders
    • Study Diary Assistance
    • Patient Forums
  • New Technologies